{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:05:32Z","timestamp":1789675532661,"version":"4.0.1"},"publisher-location":"Cham","reference-count":77,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030355814","type":"print"},{"value":"9783030355821","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-35582-1_2","type":"book-chapter","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T12:03:06Z","timestamp":1580990586000},"page":"17-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Erythropoietin Signaling in the Microenvironment of Tumors and Healthy Tissues"],"prefix":"10.1007","author":[{"given":"Wuling","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnapriya M.","family":"Varier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klarke M.","family":"Sample","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldad","family":"Zacksenhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu","family":"Gajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaacov","family":"Ben-David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1182\/blood.V81.9.2223.2223","volume":"81","author":"H Youssoufian","year":"1993","unstructured":"Youssoufian H, Longmore G, Neumann D, Yoshimura A, Lodish HF (1993) Structure, function, and activation of the erythropoietin receptor. Blood 81:2223\u20132236","journal-title":"Blood"},{"issue":"6","key":"2_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1440-169X.1993.00711.x","volume":"35","author":"Y Yasuda","year":"1993","unstructured":"Yasuda Y, Nagao M, Okano M, Masuda S, Sasaki R et al (1993) Localization of erythropoietin and erythropoietin-receptor in post-implantation mouse embryos. Dev Growth Differ 35(6):711\u2013722. https:\/\/doi.org\/10.1111\/j.1440-169X.1993.00711.x","journal-title":"Dev Growth Differ"},{"key":"2_CR3","first-page":"293","volume":"42","author":"MHL Snow","year":"1977","unstructured":"Snow MHL (1977) Gastrulation in the mouse: growth and regionalization of the epiblast. J Embryol Exp Morphol 42:293\u2013303. https:\/\/dev.biologists.org\/content\/42\/1\/293","journal-title":"J Embryol Exp Morphol"},{"key":"2_CR4","first-page":"215","volume":"106","author":"Y Yasuda","year":"2001","unstructured":"Yasuda Y, Fujita Y, Musha T, Tanaka H, Shiokawa S, Nakamatsu K et al (2001) Expression of erythropoietin in human female reproductive organs. Ital J Anat Embryol 106:215\u2013222","journal-title":"Ital J Anat Embryol"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/cncr.10787","volume":"95","author":"G Acs","year":"2002","unstructured":"Acs G, Zhang PJ, Rebbeck TR, Acs P, Verma A (2002) Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Cancer 95:965\u2013981. https:\/\/doi.org\/10.1002\/cncr.10787","journal-title":"Cancer"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/01.LAB.0000020415.72863.40","volume":"82","author":"MO Arcasoy","year":"2002","unstructured":"Arcasoy MO, Amin K, Karayal AF, Chou SC, Raleigh JA et al (2002) Functional significance of erythropoietin receptor expression in breast cancer. Lab Investig 82:911\u2013918. https:\/\/doi.org\/10.1097\/01.LAB.0000020415.72863.40","journal-title":"Lab Investig"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/pros.20310","volume":"66","author":"L Feldman","year":"2006","unstructured":"Feldman L, Wang Y, Rhim JS, Bhattacharya N, Loda M, Sytkowski AJ (2006) Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells. Prostate 66:135\u2013145. https:\/\/doi.org\/10.1002\/pros.20310","journal-title":"Prostate"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1002\/ijc.25935","volume":"129","author":"TV Lopez","year":"2011","unstructured":"Lopez TV, Lappin TRJ, Maxwell P, Shi Z, Lopez-Marure R, Aguilar C et al (2011) Autocrine\/paracrine erythropoietin signaling promotes JAK\/STAT-dependent proliferation of human cervical cancer cells. Int J Cancer 129:2566\u20132576. https:\/\/doi.org\/10.1002\/ijc.25935","journal-title":"Int J Cancer"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/carcin\/bgg060","volume":"24","author":"Y Yasuda","year":"2003","unstructured":"Yasuda Y, Fujita Y, Matsuo T, Koinuma S, Hara S, Tazaki A et al (2003) Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis 24:1021\u20131029. https:\/\/doi.org\/10.1093\/carcin\/bgg060","journal-title":"Carcinogenesis"},{"issue":"9","key":"2_CR09","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1073\/pnas.081275298","volume":"98","author":"M. Mittelman","year":"2001","unstructured":"Mittelman M, Neumann D, Peled A, Kanter P, Haran-Ghera N (2003) Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models. Proc Natl Acad Sci U S A 98(9):5181\u20135186. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Erythropoietin+induces+tumor+regression+and+antitumor+immune+responses+in+murine+myeloma+models","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"2_CR10","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1182\/blood-2005-11-026823","volume":"109","author":"D Cervi","year":"2007","unstructured":"Cervi D, Shaked Y, Haeri M, Usenko T, Lee CR et al (2007) Enhanced natural-killer cell and erythropoietic activities in VEGF-A-overexpressing mice delay F-MuLV-induced erythroleukemia. Blood 109(5):2139\u20132146. https:\/\/doi.org\/10.1182\/blood-2005-11-026823","journal-title":"Blood"},{"issue":"13","key":"2_CR11","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1038\/sj.onc.1207400","volume":"23","author":"D Cervi","year":"2004","unstructured":"Cervi D, Truong AH, Lee JS, Sukhai N, Li YJ, Koki A, Ben-David Y (2004) Phosphorylation status of c-kit and EPO receptors, and the presence of wild-type p53 confer in vitro resistance of murine erythroleukemic cells to Celecoxib. Oncogene 23(13):2305\u20132314. https:\/\/doi.org\/10.1038\/sj.onc.1207400","journal-title":"Oncogene"},{"key":"2_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/srep30998","volume":"6","author":"N Deshet-Unger","year":"2016","unstructured":"Deshet-Unger N, Hiram-Bab S, Haim-Ohana Y, Mittelman M, Gabet Y, Neumann D (2016) Erythropoietin treatment in murine multiple myeloma: immune gain and bone loss. Sci Rep 6:30998. https:\/\/doi.org\/10.1038\/srep30998","journal-title":"Sci Rep"},{"issue":"6","key":"2_CR13","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/eji.200637025","volume":"37","author":"O Katz","year":"2007","unstructured":"Katz O, Gil L, Lifshitz L, Prutchi-Sagiv S, Gassmann M, Mittelman M, Neumann D (2007) Erythropoietin enhances immune responses in mice. Eur J Immunol 37(6):1584\u20131593. https:\/\/doi.org\/10.1002\/eji.200637025","journal-title":"Eur J Immunol"},{"issue":"12","key":"2_CR14","doi-asserted-by":"publisher","first-page":"14510","DOI":"10.18632\/oncotarget.7587","volume":"7","author":"A Lamanuzzi","year":"2016","unstructured":"Lamanuzzi A, Saltarella I, Ferrucci A, Ria R, Ruggieri S, Racanelli V et al (2016) Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients. Oncotarget 7(12):14510\u201314521. https:\/\/doi.org\/10.18632\/oncotarget.7587","journal-title":"Oncotarget"},{"issue":"1","key":"2_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13045-016-0306-x","volume":"9","author":"TK Vatsveen","year":"2016","unstructured":"Vatsveen TK, Sponaas AM, Tian E, Zhang Q, Misund K, Sundan A et al (2016) Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro. Hematol Oncol 9(1):75. https:\/\/doi.org\/10.1186\/s13045-016-0306-x","journal-title":"Hematol Oncol"},{"issue":"15","key":"2_CR16","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1016\/S0021-9258(19)63387-9","volume":"252","author":"T Miyake","year":"1977","unstructured":"Miyake T, Kung CK, Goldwasser E (1977) Purification of human erythropoietin. J Biol Chem 252(15):5558\u20135564","journal-title":"J Biol Chem"},{"issue":"5","key":"2_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00204-003-0444-0","volume":"77","author":"N Obara","year":"2003","unstructured":"Obara N, Imagawa S, Nakano Y, Suzuki N, Yamamoto M, Nagasawa T (2003) Suppression of erythropoietin gene expression by cadmium depends on inhibition of HIF-1, not stimulation of GATA-2. Arch Toxicol 77(5):267\u2013273. https:\/\/doi.org\/10.1007\/s00204-003-0444-0","journal-title":"Arch Toxicol"},{"issue":"2","key":"2_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/1097-4652(200002)186:2<260::AID-JCP1025>3.0.CO;2-K","volume":"186","author":"M Tabata","year":"2003","unstructured":"Tabata M, Tarumoto T, Ohmine K, Furukawa Y, Hatake K, Ozawa K et al (2003) Stimulation of GATA-2 as a mechanism of hydrogen peroxide suppression in hypoxia-induced erythropoietin gene expression. J Cell Physiol 186(2):260\u2013267. https:\/\/doi.org\/10.1002\/1097-4652(200002)186:2<260::AID-JCP1025>3.0.CO;2-K","journal-title":"J Cell Physiol"},{"issue":"1","key":"2_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.blre.2012.12.003","volume":"27","author":"VH Haase","year":"2013","unstructured":"Haase VH (2013) Regulation of erythropoiesis by hypoxia-inducible factors. Blood Rev 27(1):41\u201353. https:\/\/doi.org\/10.1016\/j.blre.2012.12.003","journal-title":"Blood Rev"},{"issue":"6","key":"2_CR20","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1182\/blood.V94.6.1864","volume":"94","author":"BL Ebert","year":"1999","unstructured":"Ebert BL, Bunn HF (1999) Regulation of the erythropoietin gene. Blood 94(6):1864\u20131877","journal-title":"Blood"},{"issue":"1","key":"2_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/153537020322800101","volume":"228","author":"JW Fisher","year":"2003","unstructured":"Fisher JW (2003) Erythropoietin: physiology and pharmacology update. Exp Biol Med 228(1):1\u201314. https:\/\/doi.org\/10.1177\/153537020322800101","journal-title":"Exp Biol Med"},{"issue":"8","key":"2_CR22","first-page":"724","volume":"83","author":"C Lacombe","year":"1998","unstructured":"Lacombe C, Mayeux P (1998) Biology of erythropoietin. Haematologica 83(8):724\u2013732","journal-title":"Haematologica"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1271\/bbb.64.1775","volume":"64","author":"R Sasaki","year":"2000","unstructured":"Sasaki R, Masuda S, Nagao M (2000) Erythropoietin: multiple physiological functions and regulation of biosynthesis. Biosci Biotechnol Biochem 64:1775\u20131793. https:\/\/doi.org\/10.1271\/bbb.64.1775","journal-title":"Biosci Biotechnol Biochem"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/BF03345232","volume":"26","author":"W Jelkmann","year":"2003","unstructured":"Jelkmann W (2003) Erythropoietin. J Endocrinol Investig 26:832\u2013837. https:\/\/doi.org\/10.1007\/BF03345232","journal-title":"J Endocrinol Investig"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2174\/156720208784310231","volume":"5","author":"K Maiese","year":"2008","unstructured":"Maiese K, Chong ZZ, Hou J, Shang YC (2008) Erythropoietin and oxidative stress. Curr Neurovasc Res 5:125\u2013142","journal-title":"Curr Neurovasc Res"},{"key":"2_CR26","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/oxfordjournals.jbchem.a022809","volume":"128","author":"T Toyoda","year":"2000","unstructured":"Toyoda T, Itai T, Arakawa T, Aoki KH, Yamaguchi H (2000) Stabilization of human recombinant erythropoietin through interactions with the highly branched N-glycans. J Biochem 128:731\u2013737. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a022809","journal-title":"J Biochem"},{"issue":"6","key":"2_CR27","first-page":"36","volume":"72","author":"G Singbartl","year":"1994","unstructured":"Singbartl G (1994) Adverse events of erythropoietin in long-term and in acute\/short-term treatment. Clin Investig 72(6):36\u201343","journal-title":"Clin Investig"},{"key":"2_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/bs.vh.2017.02.008","volume":"105","author":"MJ Vazquez-Mellado","year":"2017","unstructured":"Vazquez-Mellado MJ, Monjaras-Embriz V, Rocha-Zavaleta L (2017) Erythropoietin, stem cell factor, and cancer cell migration. Vitam Horm 105:273\u2013291. https:\/\/doi.org\/10.1016\/bs.vh.2017.02.008","journal-title":"Vitam Horm"},{"issue":"3","key":"2_CR29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1172\/JCI114763","volume":"86","author":"AD D\u2019Andrea","year":"1990","unstructured":"D\u2019Andrea AD, Zon LI (1990) Erythropoietin receptor. Subunit structure and activation. J Clin Invest 86(3):681\u2013687. https:\/\/doi.org\/10.1172\/JCI114763","journal-title":"J Clin Invest"},{"issue":"6","key":"2_CR30","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/S1097-2765(01)00401-4","volume":"8","author":"LJ Huang","year":"2001","unstructured":"Huang LJ, Constantinescu SN, Lodish HF (2001) The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Mol Cell 8(6):1327\u20131338. https:\/\/doi.org\/10.1016\/S1097-2765(01)00401-4","journal-title":"Mol Cell"},{"issue":"23","key":"2_CR78","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1182\/blood-2014-11-575357","volume":"125","author":"D Kuhrt","year":"2015","unstructured":"Kuhrt D, Wojchowski DM (2015) Emerging EPO and EPO receptor regulators and signal transducers. Blood 125(23):3536\u20133541. https:\/\/doi.org\/10.1182\/blood-2014-11-575357","journal-title":"Blood"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1111\/j.1525-1438.2006.00709.x","volume":"16","author":"SM Temkin","year":"2006","unstructured":"Temkin SM, Hellmann M, Serur E, Lee YC, Abulafia O (2006) Erythropoietin administration during primary treatment for locally advanced cervical carcinoma is associated with poor response to radiation. Int J Gynecol Cancer 16:1855\u20131861. https:\/\/doi.org\/10.1111\/j.1525-1438.2006.00709.x","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"2_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cell.2012.01.051","volume":"149","author":"EB Rankin","year":"2012","unstructured":"Rankin EB, Wu C, Khatri R, Wilson TL, Andersen R, Araldi E et al (2012) The HIF signaling pathway in osteoblasts directly modulates erythropoiesis through the production of EPO. Cell 149(1):63\u201374. https:\/\/doi.org\/10.1016\/j.cell.2012.01.051","journal-title":"Cell"},{"issue":"1","key":"2_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3109\/08977194.2011.637034","volume":"30","author":"SJ McGee","year":"2012","unstructured":"McGee SJ, Havens AM, Shiozawa Y, Jung Y, Taichman RS (2012) Effects of erythropoietin on the bone microenvironment. Growth Factors 30(1):22\u201328. https:\/\/doi.org\/10.3109\/08977194.2011.637034","journal-title":"Growth Factors"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.critrevonc.2004.11.005","volume":"54","author":"V Munugalavadla","year":"2005","unstructured":"Munugalavadla V, Kapur R (2005) Role of c-kit and erythropoietin receptor in erythropoiesis. Crit Rev Oncol Hematol 54:63\u201375. https:\/\/doi.org\/10.1016\/j.critrevonc.2004.11.005","journal-title":"Crit Rev Oncol Hematol"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0092-8674(93)90414-l","volume":"74","author":"BA Witthuhn","year":"1993","unstructured":"Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O et al (1993) JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227\u2013236. https:\/\/doi.org\/10.1016\/0092-8674(93)90414-l","journal-title":"Cell"},{"key":"2_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1182\/blood.v99.1.102","volume":"99","author":"K Kirito","year":"2002","unstructured":"Kirito K, Nakajima K, Watanabe T, Uchida M, Tanaka M et al (2002) Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation. Blood 99:102\u2013110. https:\/\/doi.org\/10.1182\/blood.v99.1.102","journal-title":"Blood"},{"key":"2_CR37","doi-asserted-by":"publisher","first-page":"8324","DOI":"10.1073\/pnas.93.16.8324","volume":"93","author":"U Klingmuller","year":"1996","unstructured":"Klingmuller U, Bergelson S, Hsiao JG, Lodish HF (1996) Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5. Proc Natl Acad Sci U S A 93:8324\u20138328. https:\/\/doi.org\/10.1073\/pnas.93.16.8324","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR38","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1182\/blood.V93.11.3757","volume":"93","author":"H Bao","year":"1999","unstructured":"Bao H, Jacobs-Helber SM, Lawson AE, Penta K, Wickrema A, Sawyer ST (1999) Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant sub clone (HCD57-SREI cells). Blood 93:3757\u20133773","journal-title":"Blood"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.1002\/j.1460-2075.1995.tb00243.x","volume":"14","author":"JE Damen","year":"1995","unstructured":"Damen JE, Wakao H, Miyajima A, Krosl J, Humphries RK, Cutler RL et al (1995) Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J 14:5557\u20135568. https:\/\/doi.org\/10.1002\/j.1460-2075.1995.tb00243.x","journal-title":"EMBO J"},{"key":"2_CR40","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1113\/jphysiol.2008.160887","volume":"586","author":"JS Lin","year":"2008","unstructured":"Lin JS, Chen YS, Chiang HS, Ma MC (2008) Hypoxic preconditioning protects rat hearts against ischaemia-reperfusion injury: role of erythropoietin on progenitor cell mobilization. J Physiol 586:5757\u20135769. https:\/\/doi.org\/10.1113\/jphysiol.2008.160887","journal-title":"J Physiol"},{"key":"2_CR41","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/j.yexcr.2013.04.008","volume":"319","author":"N Liu","year":"2013","unstructured":"Liu N, Tian J, Cheng J, Zhang J (2013) Effect of erythropoietin on the migration of bone marrow-derived mesenchymal stem cells to the acute kidney injury microenvironment. Exp Cell Res 319:2019\u20132027. https:\/\/doi.org\/10.1016\/j.yexcr.2013.04.008","journal-title":"Exp Cell Res"},{"key":"2_CR42","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1161\/CIRCULATIONAHA.105.583732","volume":"113","author":"K Satoh","year":"2006","unstructured":"Satoh K, Kagaya Y, Nakano M, Ito Y, Ohta J, Tada H et al (2006) Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice. Circulation 113:1442\u20131450. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.583732","journal-title":"Circulation"},{"key":"2_CR43","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1182\/blood-2003-01-0223","volume":"102","author":"C Heeschen","year":"2003","unstructured":"Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C et al (2003) Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102:1340\u20131346. https:\/\/doi.org\/10.1182\/blood-2003-01-0223","journal-title":"Blood"},{"issue":"2","key":"2_CR44","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.stem.2011.07.001","volume":"9","author":"M Hoch","year":"2011","unstructured":"Hoch M, Fischer P, Stapel B, Missol-Kolka E, Sekkali B, Scherr M et al (2011) Erythropoietin preserves the endothelial differentiation capacity of cardiac progenitor cells and reduces heart failure during anticancer therapies. Cell Stem Cell 9(2):131\u2013143. https:\/\/doi.org\/10.1016\/j.stem.2011.07.001","journal-title":"Cell Stem Cell"},{"key":"2_CR45","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000132794","volume":"51","author":"HH Ropers","year":"1989","unstructured":"Ropers HH, Craig IW (1989) REPOrt of the committee on the genetic constitution of chromosomes 12 and 13. Cytogenet Cell Genet 51:259\u2013279. https:\/\/doi.org\/10.1159\/000132794","journal-title":"Cytogenet Cell Genet"},{"key":"2_CR46","doi-asserted-by":"publisher","first-page":"6406","DOI":"10.1074\/jbc.272.10.6406","volume":"272","author":"YR Hsu","year":"1997","unstructured":"Hsu YR, Wu GM, Mendiaz EA, Syed R, Wypych J, Toso R et al (1997) The majority of stem cell factor exists as monomer under physiological conditions. Implications for dimerization mediating biological activity. J Biol Chem 272:6406\u20136415. https:\/\/doi.org\/10.1074\/jbc.272.10.6406","journal-title":"J Biol Chem"},{"key":"2_CR47","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1182\/blood.V81.3.656.656","volume":"81","author":"KE Langley","year":"1993","unstructured":"Langley KE, Bennett LG, Wypych J, Yancik SA, Liu XD, Westcott KR et al (1993) Soluble stem cell factor in human serum. Blood 81:656\u2013660","journal-title":"Blood"},{"key":"2_CR48","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/sj.emboj.7601545","volume":"26","author":"H Liu","year":"2007","unstructured":"Liu H, Chen X, Focia PJ, He X (2007) Structural basis for stem cell factor-kit signaling and activation of class III receptor tyrosine kinases. EMBO J 26:891\u2013901. https:\/\/doi.org\/10.1038\/sj.emboj.7601545","journal-title":"EMBO J"},{"key":"2_CR49","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1007\/s00018-004-4189-6","volume":"61","author":"L Ronnstrand","year":"2004","unstructured":"Ronnstrand L (2004) Signal transduction via the stem cell factor receptor\/c-kit. Cell Mol Life Sci 61:2535\u20132548. https:\/\/doi.org\/10.1007\/s00018-004-4189-6","journal-title":"Cell Mol Life Sci"},{"key":"2_CR50","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/347667a0","volume":"347","author":"Y Matsui","year":"1990","unstructured":"Matsui Y, Zsebo KM, Hogan BL (1990) Embryonic expression of a haematopoietic growth factor encoded by the Sl locus and the ligand for c-kit. Nature 347:667\u2013669. https:\/\/doi.org\/10.1038\/347667a0","journal-title":"Nature"},{"key":"2_CR51","doi-asserted-by":"publisher","first-page":"18600","DOI":"10.1074\/jbc.M311643200","volume":"279","author":"J Matsui","year":"2004","unstructured":"Matsui J, Wakabayashi T, Asada M, Yoshimatsu K, Okada M (2004) Stem cell factor\/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells. J Biol Chem 279:18600\u201318607. https:\/\/doi.org\/10.1074\/jbc.M311643200","journal-title":"J Biol Chem"},{"key":"2_CR52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3892\/ijmm.2014.1773","volume":"34","author":"J Guo","year":"2014","unstructured":"Guo J, Jie W, Shen Z, Li M, Lan Y, Kong Y et al (2014) SCF increases cardiac stem cell migration through PI3K\/AKT and MMP-2\/\u22129 signaling. Int J Mol Med 34:112\u2013118. https:\/\/doi.org\/10.3892\/ijmm.2014.1773","journal-title":"Int J Mol Med"},{"key":"2_CR53","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1634\/stemcells.2006-0687","volume":"25","author":"WM Brown","year":"2007","unstructured":"Brown WM, Maxwell P, Graham AN, Yakkundi A, Dunlop EA, Shi Z et al (2007) Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificity. Stem Cells 25:718\u2013722. https:\/\/doi.org\/10.1634\/stemcells.2006-0687","journal-title":"Stem Cells"},{"key":"2_CR54","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1182\/blood-2005-10-4066","volume":"107","author":"S Elliott","year":"2006","unstructured":"Elliott S, Busse L, Bass MB, Lu H, Sarosi I, Sinclair AM et al (2006) Anti-EPO receptor antibodies do not predict EPO receptor expression. Blood 107:1892\u20131895. https:\/\/doi.org\/10.1182\/blood-2005-10-4066","journal-title":"Blood"},{"key":"2_CR55","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2967\/jnumed.111.091124","volume":"53","author":"D Doleschel","year":"2012","unstructured":"Doleschel D, Mundigl O, Wessner A, Gremse F, Bachmann J, Rodriguez A et al (2012) Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts. J Nucl Med 53:304\u2013311. https:\/\/doi.org\/10.2967\/jnumed.111.091124","journal-title":"J Nucl Med"},{"key":"2_CR56","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s00330-014-3413-5","volume":"25","author":"F Fuge","year":"2015","unstructured":"Fuge F, Doleschel D, Rix A, Gremse F, Wessner A, Winz O et al (2015) In-vivo detection of the erythropoietin receptor in tumours using positron emission tomography. Eur Radiol 25:472\u2013479. https:\/\/doi.org\/10.1007\/s00330-014-3413-5","journal-title":"Eur Radiol"},{"key":"2_CR57","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1158\/1541-7786.MCR-09-0264","volume":"8","author":"Z Shi","year":"2010","unstructured":"Shi Z, Hodges VM, Dunlop EA, Percy MJ, Maxwell AP, El-Tanani M et al (2010) Erythropoietin-induced activation of the JAK2\/STAT6, PI3K\/Akt, and Ras\/ERK pathways promotes malignant cell behaviour in a modified breast cancer cell line. Mol Cancer Res 8:615\u2013626. https:\/\/doi.org\/10.1158\/1541-7786.MCR-09-0264","journal-title":"Mol Cancer Res"},{"key":"2_CR58","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cellsig.2006.08.014","volume":"19","author":"M Um","year":"2007","unstructured":"Um M, Gross AW, Lodish HF (2007) A \u201cclassical\u201d homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastomaSH-SY5Y and pheochromocytoma PC-12 cells. Cell Signal 19:634\u2013645. https:\/\/doi.org\/10.1016\/j.cellsig.2006.08.014","journal-title":"Cell Signal"},{"key":"2_CR59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4161\/cbt.26717","volume":"15","author":"K Liang","year":"2014","unstructured":"Liang K, Qiu S, Lu Y, Fan Z (2014) Autocrine\/paracrine erythropoietin regulates migration and invasion potential and the stemness of human breast cancer cell. Cancer Biol Ther 15:89\u201398. https:\/\/doi.org\/10.4161\/cbt.26717","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"2_CR60","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ccell.2015.09.008","volume":"28","author":"S Pradeep","year":"2015","unstructured":"Pradeep S, Huang J, Mora EM, Nick AM, Cho MS, Wu SY et al (2015) Erythropoietin stimulates tumor growth via EphB4. Cancer Cell 28(5):610\u2013622. https:\/\/doi.org\/10.1016\/j.ccell.2015.09.008","journal-title":"Cancer Cell"},{"key":"2_CR61","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/ijc.23068","volume":"122","author":"JY Jeong","year":"2008","unstructured":"Jeong JY, Feldman L, Solar P, Szenajch J, Sytkowski J (2008) Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells. Int J Cancer 122:274\u2013280. https:\/\/doi.org\/10.1002\/ijc.23068","journal-title":"Int J Cancer"},{"key":"2_CR62","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3892\/or.2012.1795","volume":"28","author":"P Solar","year":"2012","unstructured":"Solar P, Hrckova G, Varinska L, Solarova Z, Kriska J, Uhrinova I et al (2012) Location and the functionality of erythropoietin receptor(s) in A2780 cells. Oncol Rep 28:141\u2013146. https:\/\/doi.org\/10.3892\/or.2012.1795","journal-title":"Oncol Rep"},{"key":"2_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077459","volume":"8","author":"A Rozsas","year":"2013","unstructured":"Rozsas A, Berta J, Rojko L, Horvath LZ, Keszthelyi M, Kenessey I et al (2013) Erythropoietin receptor expression is a potential prognostic factor in human lung adenocarcinoma. PLoS One 8:e77459. https:\/\/doi.org\/10.1371\/journal.pone.0077459","journal-title":"PLoS One"},{"issue":"9","key":"2_CR64","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1073\/pnas.081275298","volume":"98","author":"M Mittelman","year":"2001","unstructured":"Mittelman M, Neumann D, Peled A, Kanter P, Haran-Ghera N (2001) Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models. Proc Natl Acad Sci U S A 98(9):5181\u20135186. https:\/\/doi.org\/10.1073\/pnas.081275298","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR65","first-page":"1405","volume":"12","author":"JC Howard","year":"1996","unstructured":"Howard JC, Berger L, Bani MR, Hawley RG, Ben-David Y (1996) Activation of the erythropoietin gene in the majority of F-MuLV induced erythroleukemias results in growth factor independence and enhanced tumorigenicity. Oncogene 12:1405\u20131415","journal-title":"Oncogene"},{"key":"2_CR66","first-page":"2721","volume":"8","author":"JC Howard","year":"1993","unstructured":"Howard JC, Yosefi S, Cheong G, Bernstein A, Ben-David Y (1993) Temporal order of the mutation of Fli-1, p53 and erythropoietin genes during the multistep erythroleukemias induced by F-MuLV. Oncogene 8:2721\u20132729","journal-title":"Oncogene"},{"key":"2_CR67","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1182\/blood-2004-08-3210","volume":"105","author":"Y Shaked","year":"2005","unstructured":"Shaked Y, Cervi D, Neuman M, Klement G, Michaud CR, Haeri M et al (2005) The splenic microenvironment is a source of angiogenesis\/inflammatory mediators accelerating the expansion of murine erythroleukemic cells. Blood 105:4500\u20134507. https:\/\/doi.org\/10.1182\/blood-2004-08-3210","journal-title":"Blood"},{"issue":"3","key":"2_CR68","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1158\/0008-5472.CAN-09-3592","volume":"70","author":"LM Vecchiarelli-Federico","year":"2010","unstructured":"Vecchiarelli-Federico LM, Cervi D, Haeri M, Li Y, Nagy A, Ben-David Y (2010) Vascular endothelial growth factor--a positive and negative regulator of tumor growth. Cancer Res 70(3):863\u2013867. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3592","journal-title":"Cancer Res"},{"key":"2_CR69","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1182\/blood-2008-11-187419","volume":"114","author":"T Usenko","year":"2009","unstructured":"Usenko T, Li YJ, Haeri M, Li Y, Vecchiarelli-Federico LM, Zhao X et al (2009) Enrichment of Sca1+ hematopoietic progenitors in polycythemic mice inhibits leukemogenesis. Blood 114:1831\u20131841. https:\/\/doi.org\/10.1182\/blood-2008-11-187419","journal-title":"Blood"},{"key":"2_CR70","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1182\/blood-2006-10-053850","volume":"110","author":"JW Cui","year":"2007","unstructured":"Cui JW, Li YJ, Sarkar A, Brown J, Tan YH et al (2007) Retroviral insertional activation of the Fli-3 locus in erythroleukemias encoding a cluster of microRNAs that convert EPO-induced differentiation to proliferation. Blood 110:2631\u20132640. https:\/\/doi.org\/10.1182\/blood-2006-10-053850","journal-title":"Blood"},{"key":"2_CR71","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1038\/onc.2014.162","volume":"35","author":"Y Li","year":"2015","unstructured":"Li Y, Luo H, Liu T, Zachsenhaus E, Ben-David Y (2015) The transcription factor Fli-1 in development, cancer and disease. Oncogene 35:2022\u20132031. https:\/\/doi.org\/10.1038\/onc.2014.162","journal-title":"Oncogene"},{"issue":"7","key":"2_CR071","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.amjmed.2003.12.008","volume":"116","author":"Kevin Knight","year":"2004","unstructured":"Knight K, Wade S, Balducci L (2004) Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med. 116:11S\u201326S. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15050883","journal-title":"The American Journal of Medicine"},{"key":"2_CR72","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3389\/fimmu.2014.00563","volume":"5","author":"N Debeljak","year":"2014","unstructured":"Debeljak N, Sol\u00e1r P, Sytkowski AJ (2014) Erythropoietin and cancer: the unintended consequences of anemia correction. Front Immunol 5:563. https:\/\/doi.org\/10.3389\/fimmu.2014.00563","journal-title":"Front Immunol"},{"issue":"14","key":"2_CR73","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/jnci\/djt145","volume":"105","author":"V Moebus","year":"2013","unstructured":"Moebus V, Jackisch C, Schneeweiss A, Huober J, Lueck HJ, du Bois A et al (2013) Adding EPOetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial. J Natl Cancer Inst 105(14):1018\u20132610. https:\/\/doi.org\/10.1093\/jnci\/djt145","journal-title":"J Natl Cancer Inst"},{"key":"2_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003407.pub5","volume":"12","author":"T Tonia","year":"2012","unstructured":"Tonia T, Mettler A, Robert N, Schwarzer G, Seidenfeld J, Weingart O et al (2012) Erythropoietin or darbEPOetin for patients with cancer. Cochrane Database Syst Rev 12:CD003407. https:\/\/doi.org\/10.1002\/14651858.CD003407.pub5","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Advances in Experimental Medicine and Biology","Tumor Microenvironment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-35582-1_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T23:56:42Z","timestamp":1614297402000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-35582-1_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030355814","9783030355821"],"references-count":77,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-35582-1_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"7 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}